Article

Epigenetic markers of tumor progression in estrogen receptor–positive breast cancer patients with high nodal involvement

2025-10-29

Abstract excerpt

<title>Abstract</title> <p> Background Management of axillary lymph node (LN) disease in breast cancer (BC) is evolving, with declining use of axillary lymph node dissection. Consequently, prognostic information from nodal assessment is becoming limited. Molecular determinants of primary tumors associated with greater nodal burden could provide complementary prognostic value and mechanistic insights into progres...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a5931e6e-b710-53cd-a35b-e2433b352547
DOI: 10.21203/rs.3.rs-7966078/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Epigenetic markers of tumor progression in estrogen receptor–positive breast cancer patients with high nodal involvementDOI 10.21203/rs.3.rs-7966078/v1Read

Tumor-Intrinsic Epigenetic Programs Associated with Nodal Burden and Metastatic Risk in ER+/HER2- Breast CancerSemantic proximity Read

A seven-gene CpG-island methylation panel predicts breast cancer progressionSemantic proximity Read

Epigenetic programs shaping lung metastasis in triple-negative breast cancerSemantic proximity Read

Spatial Transcriptomic Profiling Uncovers Tumor Heterogeneity and Microenvironmental Features Associated with Lymph Node Metastasis in Invasive Lobular CarcinomaSemantic proximity Read

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasisSemantic proximity Read

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceSemantic proximity Read

Clinical Validation of RlapsRisk BC in an international multi-cohorts settingSemantic proximity Read

Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancerSemantic proximity Read

Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer.Semantic proximity Read

DNA Methylation Signatures in Breast Cancer: A Systematic Review and Meta-AnalysisSemantic proximity Read

Whole transcriptome analysis reveal MammaPrint and BluePrint-associated gene expression patterns with early lymph node metastasis in early-stage breast cancerSemantic proximity Read

Decoding gene regulatory circuitry underlying TNBC chemoresistance reveals biomarkers for therapy response and therapeutic targetsSemantic proximity Read